Do thiazolidine compounds act on intracellular amastigotes of Trypanosoma cruzi? A systematic review

Detalhes bibliográficos
Autor(a) principal: Silva Júnior, José Noé da
Data de Publicação: 2022
Outros Autores: Calaça, Priscilla Régia de Andrade, Moura, Yanara Alessandra Santana, Amorim, Andreza Pereira de, Silva, Ana Carla da, Bezerra, Raquel Pedrosa, Lorena, Virginia Maria Barros, Marques, Daniela de Araújo Viana, Caires, Silvana de Fátima Ferreira, Porto, Ana Lúcia Figueiredo
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/26531
Resumo: Benznidazole (Bdz) are the drug of choice to treat Chagas Disease. However, the drug causes several side effects, and Trypanosoma cruzi, the etiological agent of Chagas disease, can be less susceptible to the action of drugs in the chronic phase, due to its reduced metabolism and dormancy in tissues. Thus, using compounds that are lethal to amastigote forms, which are prevalent in the Chagas disease chronic phase, is essential for the success of therapy. We propose to evaluate, though a systematic review, the efficacy of thiazolidine and its imidazolidine derivatives against T. cruzi intracellular amastigotes, and to compare the results with those for Bdz, A systematic search was made on eight English Language Systematic Databases - Science Direct, Scopus, Pubmed, Google Scholar, LILACS, Scielo, Trip Database and Cochrane, to collect studies, without a time scale. IC50 values, cytotoxic effects (CC50), a selective index (SI), the mechanism of action of each compound and the length of treatment was included in this review to evaluate the effectiveness of each compound. The compound 2-Iminothiazolidin-4-one 18 was more effective than Bdz, as it affected intracellular amastigotes by making a structural modification in the parasite, and by inhibiting cruzain, being promising for the antichagasic therapy.
id UNIFEI_d8b7fa7bff1ad2c29d5aa9c037d60a14
oai_identifier_str oai:ojs.pkp.sfu.ca:article/26531
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Do thiazolidine compounds act on intracellular amastigotes of Trypanosoma cruzi? A systematic reviewActuan los compuestos tiazolidinicos sobre los amastigotas intracelulares de Trypanosoma cruzi? Una revisión sistemáticaCompostos tiazolidínicos atuam sobre formas amastigotas de Trypanosoma cruzi? Uma revisão sistemáticaTratamiento alternativoFármacos antichagásicasAmastigotes intracelularesBenznidazoleCompuestos tiazolidinicos.Tratamento alternaticoDrogas antichagásicasBenznidazolAmastigotas intracelularesCompostos tiazolidínicos.Alternative treatmentAntichagasic drugsBenznidazoleIntracellular amastigotesThiazolidine compounds.Benznidazole (Bdz) are the drug of choice to treat Chagas Disease. However, the drug causes several side effects, and Trypanosoma cruzi, the etiological agent of Chagas disease, can be less susceptible to the action of drugs in the chronic phase, due to its reduced metabolism and dormancy in tissues. Thus, using compounds that are lethal to amastigote forms, which are prevalent in the Chagas disease chronic phase, is essential for the success of therapy. We propose to evaluate, though a systematic review, the efficacy of thiazolidine and its imidazolidine derivatives against T. cruzi intracellular amastigotes, and to compare the results with those for Bdz, A systematic search was made on eight English Language Systematic Databases - Science Direct, Scopus, Pubmed, Google Scholar, LILACS, Scielo, Trip Database and Cochrane, to collect studies, without a time scale. IC50 values, cytotoxic effects (CC50), a selective index (SI), the mechanism of action of each compound and the length of treatment was included in this review to evaluate the effectiveness of each compound. The compound 2-Iminothiazolidin-4-one 18 was more effective than Bdz, as it affected intracellular amastigotes by making a structural modification in the parasite, and by inhibiting cruzain, being promising for the antichagasic therapy.El benznidazol (Bdz) es el fármaco de elección para tratar la enfermedad de Chagas. Sin embargo, el fármaco provoca varios efectos secundarios, y Trypanosoma cruzi, el agente etiológico de la enfermedad de Chagas, puede ser menos susceptible a la acción de los fármacos en la fase crónica, debido a su metabolismo reducido y latencia en los tejidos. En ese contexto, el uso de compuestos letales para las formas de amastigote, que son frecuentes en la fase crónica de la enfermedad de Chagas, es esencial para el éxito de la terapia. Proponemos evaluar, a través de una revisión sistemática, la eficacia de compuestos tiazolidinicos y sus derivados de imidazolidinicos contra los amastigotes intracelulares de T. cruzi, y comparar estos dados con los de Bdz. Se realizó una búsqueda sistemática en ocho bases de datos sistemáticas en idioma inglés - Science Direct, Scopus, Pubmed, Google Scholar, LILACS, Scielo, Trip Database y Cochrane, para recolectar estudios, sin escala de tiempo. Los valores IC50, los efectos citotóxicos (CC50), índice de selectividad (ISe), el mecanismo de acción de cada compuesto y la duración del tratamiento se incluyeron en esta revisión para evaluar la eficacia de cada compuesto. El compuesto 2-Iminothiazolidin-4-one 18 fue más efectivo que Bdz, ya que afectó a los amastigotes intracelulares al realizar una modificación estructural en el parásito, así como inhibindo la cruzaína, siendo un compuesto promisorio para la terapia antichagásica.O Benznidazol (Bdz) é a droga de escolha para o tratamento da doença de Chagas. No entanto, o medicamento possui vários efeitos colaterais, e o Trypanosoma cruzi, agente etiológico da doença de Chagas, pode ser menos suscetível à ação de drogas na fase crônica, devido ao seu metabolismo reduzido e dormência nos tecidos. Assim, a utilização de compostos letais às formas amastigotas, prevalentes na fase crônica da doença de Chagas, é essencial para o sucesso da terapia. Nesse contexto, propomos avaliar, através de uma revisão sistemática, a eficácia de compostos tiazóis e seus derivados imidazóis contra amastigotas intracelulares de T. cruzi, e comparar esses dados com a eficácia do Bdz. Scopus, Pubmed, Google Scholar, LILACS, Scielo, Trip Database e Cochrane, para coleta de estudos, sem escala de tempo. Valores de IC50, efeitos citotóxicos (CC50), Índice de seletividade (ISe), o mecanismo de ação de cada composto, e a duração do tratamento foram incluídos neste estudo para avaliar a eficácia de cada composto. O composto 2-iminotiazolidin-4-ona 18 foi mais eficaz que o Bdz, afetando as formas amastigotas intracelulares através de modificação estrutural no parasita, e por inibição da cruzaína, sendo considerado um composto promissor para a terapia antichagásica.Research, Society and Development2022-02-28info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2653110.33448/rsd-v11i3.26531Research, Society and Development; Vol. 11 No. 3; e38611326531Research, Society and Development; Vol. 11 Núm. 3; e38611326531Research, Society and Development; v. 11 n. 3; e386113265312525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIenghttps://rsdjournal.org/index.php/rsd/article/view/26531/23355Copyright (c) 2022 José Noé da Silva Júnior; Priscilla Régia de Andrade Calaça; Yanara Alessandra Santana Moura; Andreza Pereira de Amorim; Ana Carla da Silva; Raquel Pedrosa Bezerra; Virginia Maria Barros Lorena; Daniela de Araújo Viana Marques; Silvana de Fátima Ferreira Caires; Ana Lúcia Figueiredo Portohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva Júnior, José Noé daCalaça, Priscilla Régia de Andrade Moura, Yanara Alessandra Santana Amorim, Andreza Pereira deSilva, Ana Carla daBezerra, Raquel Pedrosa Lorena, Virginia Maria Barros Marques, Daniela de Araújo Viana Caires, Silvana de Fátima Ferreira Porto, Ana Lúcia Figueiredo 2022-03-09T13:44:38Zoai:ojs.pkp.sfu.ca:article/26531Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:44:33.063656Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Do thiazolidine compounds act on intracellular amastigotes of Trypanosoma cruzi? A systematic review
Actuan los compuestos tiazolidinicos sobre los amastigotas intracelulares de Trypanosoma cruzi? Una revisión sistemática
Compostos tiazolidínicos atuam sobre formas amastigotas de Trypanosoma cruzi? Uma revisão sistemática
title Do thiazolidine compounds act on intracellular amastigotes of Trypanosoma cruzi? A systematic review
spellingShingle Do thiazolidine compounds act on intracellular amastigotes of Trypanosoma cruzi? A systematic review
Silva Júnior, José Noé da
Tratamiento alternativo
Fármacos antichagásicas
Amastigotes intracelulares
Benznidazole
Compuestos tiazolidinicos.
Tratamento alternatico
Drogas antichagásicas
Benznidazol
Amastigotas intracelulares
Compostos tiazolidínicos.
Alternative treatment
Antichagasic drugs
Benznidazole
Intracellular amastigotes
Thiazolidine compounds.
title_short Do thiazolidine compounds act on intracellular amastigotes of Trypanosoma cruzi? A systematic review
title_full Do thiazolidine compounds act on intracellular amastigotes of Trypanosoma cruzi? A systematic review
title_fullStr Do thiazolidine compounds act on intracellular amastigotes of Trypanosoma cruzi? A systematic review
title_full_unstemmed Do thiazolidine compounds act on intracellular amastigotes of Trypanosoma cruzi? A systematic review
title_sort Do thiazolidine compounds act on intracellular amastigotes of Trypanosoma cruzi? A systematic review
author Silva Júnior, José Noé da
author_facet Silva Júnior, José Noé da
Calaça, Priscilla Régia de Andrade
Moura, Yanara Alessandra Santana
Amorim, Andreza Pereira de
Silva, Ana Carla da
Bezerra, Raquel Pedrosa
Lorena, Virginia Maria Barros
Marques, Daniela de Araújo Viana
Caires, Silvana de Fátima Ferreira
Porto, Ana Lúcia Figueiredo
author_role author
author2 Calaça, Priscilla Régia de Andrade
Moura, Yanara Alessandra Santana
Amorim, Andreza Pereira de
Silva, Ana Carla da
Bezerra, Raquel Pedrosa
Lorena, Virginia Maria Barros
Marques, Daniela de Araújo Viana
Caires, Silvana de Fátima Ferreira
Porto, Ana Lúcia Figueiredo
author2_role author
author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva Júnior, José Noé da
Calaça, Priscilla Régia de Andrade
Moura, Yanara Alessandra Santana
Amorim, Andreza Pereira de
Silva, Ana Carla da
Bezerra, Raquel Pedrosa
Lorena, Virginia Maria Barros
Marques, Daniela de Araújo Viana
Caires, Silvana de Fátima Ferreira
Porto, Ana Lúcia Figueiredo
dc.subject.por.fl_str_mv Tratamiento alternativo
Fármacos antichagásicas
Amastigotes intracelulares
Benznidazole
Compuestos tiazolidinicos.
Tratamento alternatico
Drogas antichagásicas
Benznidazol
Amastigotas intracelulares
Compostos tiazolidínicos.
Alternative treatment
Antichagasic drugs
Benznidazole
Intracellular amastigotes
Thiazolidine compounds.
topic Tratamiento alternativo
Fármacos antichagásicas
Amastigotes intracelulares
Benznidazole
Compuestos tiazolidinicos.
Tratamento alternatico
Drogas antichagásicas
Benznidazol
Amastigotas intracelulares
Compostos tiazolidínicos.
Alternative treatment
Antichagasic drugs
Benznidazole
Intracellular amastigotes
Thiazolidine compounds.
description Benznidazole (Bdz) are the drug of choice to treat Chagas Disease. However, the drug causes several side effects, and Trypanosoma cruzi, the etiological agent of Chagas disease, can be less susceptible to the action of drugs in the chronic phase, due to its reduced metabolism and dormancy in tissues. Thus, using compounds that are lethal to amastigote forms, which are prevalent in the Chagas disease chronic phase, is essential for the success of therapy. We propose to evaluate, though a systematic review, the efficacy of thiazolidine and its imidazolidine derivatives against T. cruzi intracellular amastigotes, and to compare the results with those for Bdz, A systematic search was made on eight English Language Systematic Databases - Science Direct, Scopus, Pubmed, Google Scholar, LILACS, Scielo, Trip Database and Cochrane, to collect studies, without a time scale. IC50 values, cytotoxic effects (CC50), a selective index (SI), the mechanism of action of each compound and the length of treatment was included in this review to evaluate the effectiveness of each compound. The compound 2-Iminothiazolidin-4-one 18 was more effective than Bdz, as it affected intracellular amastigotes by making a structural modification in the parasite, and by inhibiting cruzain, being promising for the antichagasic therapy.
publishDate 2022
dc.date.none.fl_str_mv 2022-02-28
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/26531
10.33448/rsd-v11i3.26531
url https://rsdjournal.org/index.php/rsd/article/view/26531
identifier_str_mv 10.33448/rsd-v11i3.26531
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/26531/23355
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 11 No. 3; e38611326531
Research, Society and Development; Vol. 11 Núm. 3; e38611326531
Research, Society and Development; v. 11 n. 3; e38611326531
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052705415364608